ReviewCurrent opinion in endocrinology, diabetes, and obesity2015

PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9.

Hagai Tavori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.